Sphingosine 1-phosphate receptor modulators for the treatment of inflammatory bowel disease and other immune-mediated diseases
Crossref DOI link: https://doi.org/10.1007/s00044-022-02961-4
Published Online: 2022-09-29
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Lifan
Lu, Peng
Wang, Yubin
Text and Data Mining valid from 2022-09-29
Version of Record valid from 2022-09-29
Article History
Received: 22 May 2022
Accepted: 23 August 2022
First Online: 29 September 2022
Compliance with ethical standards
:
: The authors declare no competing interests.